Pseudohypoaldosterism: demystification using network medicine and proposed diagnostic panels

Area of Science:

• Genetics
• Systems Biology
• Nephrology

Background:

• Pseudohypoaldosteronism (PHA) is a rare hereditary channelopathy causing renal tubular dysfunction, impaired sodium reabsorption, and potassium retention.
• Genetic forms of PHA are linked to mutations in ENaC subunits, NR3C2, CUL3, WNK1, WNK4, or KLHL3 genes.
• Digenic defects suggest a broader genetic basis for PHA.

Purpose of the Study:

• To investigate the underlying molecular mechanisms of Pseudohypoaldosteronism (PHA).
• To assess the potential role of additional genetic contributors in PHA pathogenesis.
• To explore PHA as a network-level disorder.

Main Methods:

• A systems medicine approach was employed.
• Interaction network construction and enrichment analyses were utilized.

Main Results:

• A high-confidence interactome with 53 nodes was generated, identifying CALM3 and SCN2A as central hubs.
• Enrichment analysis revealed key pathways including membrane depolarization, sodium ion transport, and aldosterone-regulated sodium reabsorption.
• Two diagnostic panels, PHA-X and PHA-4T, were developed for PHA diagnosis.

Conclusions:

• Findings support the view of PHA as a network-level disorder.
• This perspective offers new insights into PHA pathogenesis beyond isolated mutations.
• The study provides a foundation for novel diagnostic and therapeutic development in PHA.